<!DOCTYPE html>

<html lang="en">
<head>
	<meta http-equiv="Content-Type" content="text/html; charset=utf-8">
	<meta name="viewport" content="width=device-width, initial-scale=1">
	<title></title>
	<link rel="stylesheet" href="css/as.css" type="text/css" />
	<link rel="stylesheet" href="css/animate.css" type="text/css" />
	<script type="text/javascript" src="js/base.js"></script>
	<script type="text/javascript" src="js/Common.js"></script>
    <script type="text/javascript" charset="utf-8">
		
		//delay = 500;
			ANIMATION = [
				
		  	 ];

		
	</script>
    
    <style type="text/css">
	/*p {margin-top:0 !important; margin-bottom:0 !important;}*/
	</style>

</head>

<body class="slide-isi">

<div id="content">
<div class="collage"></div>

<header>
Important Safety Information<sup>1</sup>

</header>

<div class="logo"></div>

<section>



            <p><strong class="sub-head">Special Dosing Considerations</strong></p>
                <p>Special attention should be given to accurate calculation of the dose of KALETRA, transcription of the medication order, dispensing information, and dosing instructions to minimize the risk for medication errors and overdose. The appropriate dose must be carefully calculated for each pediatric patient, based on the body weight or body surface area recommendations in the full Prescribing Information, to avoid underdosing or exceeding the recommended adult dose.</p>
                
            <p><strong class="sub-head">Pregnancy</strong></p>
            <p>KALETRA should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus. There are no adequate and well-controlled studies in pregnant women taking KALETRA. Mothers should be instructed <br><u>not to breast-feed if they are receiving KALETRA</u>.</p>
            
            <p><strong class="sub-head">Adverse Reactions</strong></p>
            <p>In KALETRA clinical trials, the most common adverse reactions reported in &gt;5% of adult patients were diarrhea, nausea, abdominal pain, asthenia, vomiting, headache, and dyspepsia. In children receiving KALETRA oral solution, the most common adverse reactions were taste aversion, vomiting, and diarrhea.</p>
            

</section>
<div class="buttonwrap">
<button onclick="makecall('PopupWithHeader',Array('ps-ref','References','<table width=\'600px\'><tr align=\'center\'><td class=\'reference\'>References</td></tr></table>','90','625','10','0','585','130','1','0','1','0'));">References</button>
</div>

<footer>Please click buttons above for Indication and Important Safety Information about KALETRA.</footer>


</div>
</body>
</html>


